Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Inventory-to-Revenue : 0.10 (As of Dec. 2018)

View and export this data going back to 2014. Start your Free Trial

What is Parnell Pharmaceuticals Holdings Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Parnell Pharmaceuticals Holdings's Average Total Inventories for the quarter that ended in Dec. 2018 was $1.96 Mil. Parnell Pharmaceuticals Holdings's Revenue for the six months ended in Dec. 2018 was $19.03 Mil. Parnell Pharmaceuticals Holdings's Inventory-to-Revenue for the quarter that ended in Dec. 2018 was 0.10.

Parnell Pharmaceuticals Holdings's Inventory-to-Revenue for the quarter that ended in Dec. 2018 declined from Dec. 2017 (0.15) to Dec. 2017 (0.10)

A decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Parnell Pharmaceuticals Holdings's Days Inventory for the six months ended in Dec. 2018 was 45.30.

Inventory Turnover measures how fast the company turns over its inventory within a year. Parnell Pharmaceuticals Holdings's Inventory Turnover for the quarter that ended in Dec. 2018 was 4.03.

Parnell Pharmaceuticals Holdings Inventory-to-Revenue Historical Data

The historical data trend for Parnell Pharmaceuticals Holdings's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parnell Pharmaceuticals Holdings Inventory-to-Revenue Chart

Parnell Pharmaceuticals Holdings Annual Data

Trend

Jun12

Jun13

Jun14

Dec15

Dec16

Dec17

Dec18

Inventory-to-Revenue

Get a 7-Day Free Trial

0.20

0.15

0.18

0.15

0.10

Parnell Pharmaceuticals Holdings Semi-Annual Data
	Jun12	Jun13	Jun14	Dec15	Dec16	Dec17	Dec18
Inventory-to-Revenue	Get a 7-Day Free Trial			0.21	0.15	0.18	0.15	0.10

Competitive Comparison of Parnell Pharmaceuticals Holdings's Inventory-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Parnell Pharmaceuticals Holdings's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Parnell Pharmaceuticals Holdings's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Parnell Pharmaceuticals Holdings's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Parnell Pharmaceuticals Holdings's Inventory-to-Revenue falls into.

Parnell Pharmaceuticals Holdings Inventory-to-Revenue Calculation

Parnell Pharmaceuticals Holdings's Inventory-to-Revenue for the fiscal year that ended in Dec. 2018 is calculated as

	Inventory-to-Revenue (A: Dec. 2018 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (A: Dec. 2017 )	+	Total Inventories (A: Dec. 2018 ))	/	count )	/	Revenue (A: Dec. 2018 )
=	( (1.633	+	2.29)	/	2 )	/	19.031
=	1.9615					/	19.031
=	0.10

Parnell Pharmaceuticals Holdings's Inventory-to-Revenue for the quarter that ended in Dec. 2018 is calculated as

	Inventory-to-Revenue (Q: Dec. 2018 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (Q: Dec. 2017 )	+	Total Inventories (Q: Dec. 2018 ))	/	count )	/	Revenue (Q: Dec. 2018 )
=	( (1.633	+	2.29)	/	2 )	/	19.031
=	1.9615					/	19.031
=	0.10

Parnell Pharmaceuticals Holdings (OTCPK:PARNF) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Parnell Pharmaceuticals Holdings's Days Inventory for the six months ended in Dec. 2018 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2018 )	/	Cost of Goods Sold (Q: Dec. 2018 )	*	Days in Period
	=	1.9615	/	7.903	*	365 / 2
	=	45.30

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Parnell Pharmaceuticals Holdings's Inventory Turnover for the quarter that ended in Dec. 2018 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2018 )	/	Average Total Inventories (Q: Dec. 2018 )
	=	7.903	/	1.9615
	=	4.03

Parnell Pharmaceuticals Holdings Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Parnell Pharmaceuticals Holdings's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARNF) » Definitions » Inventory-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

476 Gardeners Road, Unit 4, Century Estate, Alexandria, Sydney, NSW, AUS, 2015

Website

https://www.parnell.com

Parnell Pharmaceuticals Holdings Ltd is an Australia based veterinary pharmaceutical company. It is focused on developing, manufacturing and commercializing animal health solutions. The group manufactures and market products for companion animals and production animals. The firm also has a pipeline of drug products like Zydax, PAR121 and PAR122 and Luminous which covers therapeutic areas in orthopedics, dermatology, and nutraceuticals. The operating segments of the company are Companion animal, Production animal - U.S., Production animal - rest of world and Contract Manufacturing. It operates internationally and generates the majority of the revenue from the Production animal - U.S. segment which covers the group's reproductive hormone portfolio across production animal in the USA.